|
|
Volumn 30, Issue 3, 2000, Pages 267-268
|
|
To the editor: Eradication of Mycobacterium abscessus in a chronically infected patient with cystic fibrosis [2]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BACTERIAL GROWTH;
CHRONIC DISEASE;
CYSTIC FIBROSIS;
GROWTH INHIBITION;
LETTER;
MYCOBACTERIUM ABSCESSUS;
PRIORITY JOURNAL;
ADULT;
DRUG COMBINATION;
DRUG EFFECT;
FEMALE;
HUMAN;
INHALATIONAL DRUG ADMINISTRATION;
LUNG ABSCESS;
MICROBIOLOGY;
MYCOBACTERIOSIS;
MYCOBACTERIUM;
ORAL DRUG ADMINISTRATION;
PATHOGENICITY;
PATHOLOGY;
RECURRENT DISEASE;
AMIKACIN;
ANTIINFECTIVE AGENT;
CLARITHROMYCIN;
ADMINISTRATION, INHALATION;
ADMINISTRATION, ORAL;
ADULT;
AMIKACIN;
ANTI-BACTERIAL AGENTS;
CHRONIC DISEASE;
CLARITHROMYCIN;
CYSTIC FIBROSIS;
DRUG THERAPY, COMBINATION;
FEMALE;
HUMANS;
LUNG ABSCESS;
MYCOBACTERIUM;
MYCOBACTERIUM INFECTIONS;
RECURRENCE;
|
|
EID: 0034268550
PISSN: 87556863
EISSN: None
Source Type: Journal
DOI: 10.1002/1099-0496(200009)30:3<267::AID-PPUL13>3.0.CO;2-H Document Type: Letter |
|
Times cited : (15)
|
|
References (3)
|
